Found 16 results

↓ CSV
Name Type of Offering Accepted Date
RespireRx Pharmaceuticals Inc. D 2017-09-13 11:30:35
Amount To Be Raised $1,150,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-17-000004
Exclusions or Exemptions 506b
Accepted Date 2017-09-13 11:30:35
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ D 2014-04-01
Amount To Be Raised $1,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-14-000002
Exclusions or Exemptions 506b
Accepted Date 2014-04-01
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. D 2017-01-13 14:09:04
Amount To Be Raised $3,000,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-01-13 14:09:04
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. D 2020-08-12 13:13:38
Amount To Be Raised $193,250
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-20-000002
Exclusions or Exemptions 506b
Accepted Date 2020-08-12 13:13:38
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Debt
CORTEX PHARMACEUTICALS INC/DE/ D 2012-08-21
Amount To Be Raised $3,832,214
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001181431-12-046840
Exclusions or Exemptions N/A
Accepted Date 2012-08-21
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. D 2016-01-20
Amount To Be Raised $2,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-16-000002
Exclusions or Exemptions 506b
Accepted Date 2016-01-20
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. D 2020-08-12 12:30:00
Amount To Be Raised $2,000,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-08-12 12:30:00
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. Artboard 1 1-A/A 2021-10-12 17:20:32
Amount To Be Raised $7,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001493152-21-025228
Accepted Date 2021-10-12 17:20:32
Type of Offering 1-A/A
Industry PHARMACEUTICAL PREPARATIONS
Offering Tier Tier2
Principal Place of Business NEW JERSEY
Revenue or Assets $0.00
State of Jurisdiction DELAWARE
Type of Security Equity (common or preferred stock)
CORTEX PHARMACEUTICALS INC/DE/ D 2009-08-06
Amount To Be Raised $5,886,291
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001181431-09-039202
Exclusions or Exemptions N/A
Accepted Date 2009-08-06
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ D 2010-01-21
Amount To Be Raised $1,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001181431-10-004318
Exclusions or Exemptions N/A
Accepted Date 2010-01-21
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
CORTEX PHARMACEUTICALS INC/DE/ D 2015-09-11
Amount To Be Raised $3,000,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001560208-15-000002
Exclusions or Exemptions 506b
Accepted Date 2015-09-11
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. D 2017-03-23 15:15:57
Amount To Be Raised $1,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-17-000002
Exclusions or Exemptions 506b
Accepted Date 2017-03-23 15:15:57
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ D 2011-10-27
Amount To Be Raised $675,057
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001181431-11-053650
Exclusions or Exemptions N/A
Accepted Date 2011-10-27
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ D 2014-11-17
Amount To Be Raised $1,000,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-14-000004
Exclusions or Exemptions 506b
Accepted Date 2014-11-17
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. D 2018-09-24 14:15:18
Amount To Be Raised $1,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0000849636-18-000001
Exclusions or Exemptions 506b
Accepted Date 2018-09-24 14:15:18
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
RespireRx Pharmaceuticals Inc. Artboard 1 1-A 2021-08-09 09:15:41
Amount To Be Raised $7,500,000
Associated Brokers / Dealers N/A
CIK Number 0000849636
Filed Document 0001493152-21-018997
Accepted Date 2021-08-09 09:15:41
Type of Offering 1-A
Industry PHARMACEUTICAL PREPARATIONS
Offering Tier Tier2
Principal Place of Business NEW JERSEY
Revenue or Assets $0.00
State of Jurisdiction DELAWARE
Type of Security Equity (common or preferred stock)